With market value expected to hit $50 billion by 2025, the region is one of the most lucrative markets for global players Be it the expanding population, unmet medical needs, growing middle class population, longer life expectancy, lower mortality rates or rising income levels, the Middle East and North Africa (MENA) region has everything that a pharmaceutical company would want. With the rise in the global demand for quality and affordable medicine and supplies, the future of pharma companies establishing…
